We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Prostate Cancer Patient Receives First Treatment of Real-Time Brachytherapy Planning System

By MedImaging International staff writers
Posted on 29 Apr 2013
Image: The Vitesse software reconstructs needles in real time using 3D ultrasound data (Photo courtesy of Varian Medical Systems).
Image: The Vitesse software reconstructs needles in real time using 3D ultrasound data (Photo courtesy of Varian Medical Systems).
A prostate cancer patient is the first individual in the world to be treated using the latest generation of a real-time planning system for planning and performing cutting-edge high-dose-rate (HDR), ultrasound-guided brachytherapy treatments.

The treatment was performed at the Levine Cancer Institute (Charlotte, NC, USA). “Our team was very impressed overall with this treatment planning system,” stated Dr. Michael Haake, chief, division of radiation oncology at Carolinas Medical Center, Levine Cancer Institute. “The total anesthesia time for the patient was just three hours, which is short for this type of treatment. He was discharged about two and half hours after he woke up.”

HDR brachytherapy involves delivering radiotherapy from inside the body by briefly placing a tiny radioactive source directly into the tumor or other targeted area. Using a robotic device called an afterloader, clinicians place the radioactive source into positions through needles that have been inserted into the region being treated. Under computer control, the source is then moved within the needles to create the specified dose distribution within the patient’s anatomy.

Using the latest version of Vitesse, developed by Varian (Palo Alto, CA, USA), HDR brachytherapy treatment plans can be created in a real-time environment, using ultrasound images generated in the operating room rather than CT scans generated postoperatively elsewhere. This avoids the need to move the patient to a CT scanner for imaging after the needles have been put in place. The process can now be completed completely within the Vitesse program, from capturing the ultrasound image to finalizing an approved treatment plan.

“From a practical point of view, the Vitesse software enabled us to monitor the location of the implant needle tips better in real time, by moving the needle as my dosimetry personnel mapped their position, which allowed us to actually leave the procedure room with a great treatment plan,” added Dr. Haake. “The real time planning allowed us to edit the plan during treatment, which would have been much more difficult and time consuming using our previous planning system.”

“This version of Vitesse reduces the number and complexity of steps involved in planning and completing a treatment,” said Tim Clark, marketing manager for Varian brachytherapy. “It eliminates the need for a data transfer to another software program, and avoids moving the patient to a CT scanner for images in the middle of the procedure. For these reasons, most clinicians will see a reduction in the amount of time needed to complete these treatments, often by as much as an hour and a half.”

Levine Cancer Institute is part of the Carolinas HealthCare System (CHS), which comprises 32 affiliated hospitals in North and South Carolina.

Related Links:
Varian
Levine Cancer Institute

Breast Localization System
MAMMOREP LOOP
Digital Color Doppler Ultrasound System
MS22Plus
Medical Radiographic X-Ray Machine
TR30N HF
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices

Channels

General/Advanced Imaging

view channel
CT and fused SPECT-CT images L to R of representative healthy control, pulmonary fibrosis participant & hypersensitivity pneumonitis participant (Image courtesy of SNMMI)

New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease

Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.